Neurobiology of Addiction: Science Meets Recovery (Clinical Track) [7131]
Date: Friday, March 9, 2018
Time: 7:45 AM - 8:45 AM
Location: Greater Columbus Convention Center
Room: Short North Ballroom A

   Susan Blank, President, Georgia Society of Addiction Medicine, Founder of the Atlanta Healing Center

Session Type: Educational Session

Thanks to neuroimaging, genetic studies and development of animal models of addiction, the field of addiction medicine has experienced significant advances in our understanding and treatment of this fascinating and oftimes, frustrating brain disease. It is important for clinicians to gain insight into the signs, symptoms, risk factors and evidenced-based interventions to assist their patients to negotiate and manage the disease of addiction. The presenter reviews the neurobiology, neurotransmitters and genetics of addiction, as well as treatment options that can be integrated into primary care and office-based pain practices.

Learning Objectives:
Identify the three neural networks involved in the disease of addiction
Explain the role of genetics, epigenetics and exposure to addictive substances in the development of the disease of addiction
List the three Food and Drug Administration approved medications for opiate use disorder, the seven for nicotine and the three for alcohol use disorder
Summarize the importance of screening for addiction, and describe how to use at least one validated screening tool

CEU Hours:  
  IACET: 0.1
  CCM: 1
  CRC: 1
  RN: 1
  CME: 1
  BWC Discount Programs: 1

Search sessions by day, speaker, keyword, session type, or display all sessions.

Return to Session Search